Continue to site >
Trending ETFs

ETFMG Treatments, Testing and Advancements ETF

ETF
GERM
Payout Change
Pending
Price as of:
$23.99 +0.73 +3.14%
primary theme
Health Care Sector Equity
GERM (ETF)

ETFMG Treatments, Testing and Advancements ETF

Payout Change
Pending
Price as of:
$23.99 +0.73 +3.14%
primary theme
Health Care Sector Equity
GERM (ETF)

ETFMG Treatments, Testing and Advancements ETF

Payout Change
Pending
Price as of:
$23.99 +0.73 +3.14%
primary theme
Health Care Sector Equity

Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$23.99

$28.2 M

0.83%

$0.20

0.68%

Vitals

YTD Return

-23.2%

1 yr return

-37.9%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$28.2 M

Holdings in Top 10

53.2%

52 WEEK LOW AND HIGH

$23.3
$20.69
$45.54

Expenses

OPERATING FEES

Expense Ratio 0.68%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover 39.00%

Redemption Fee N/A


Min Investment

Standard (Taxable)

$0

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund

Investment Style

Health


Name

Price

Aum/Mkt Cap

YIELD & DIV

Exp Ratio

Watchlist

$23.99

$28.2 M

0.83%

$0.20

0.68%

GERM - Profile

Distributions

  • YTD Total Return -32.7%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio 0.98%
DIVIDENDS
  • Dividend Yield 0.8%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    ETFMG Treatments, Testing and Advancements ETF
  • Fund Family Name
    ETFMG
  • Inception Date
    Jun 17, 2020
  • Shares Outstanding
    1200000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Devin Ryder

Fund Description

The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund invests at least 80% of its total assets in the component securities of the index. The fund is non-diversified.


GERM - Performance

Return Ranking - Trailing

Period GERM Return Category Return Low Category Return High Rank in Category (%)
YTD -23.2% -41.7% 25.3% 85.64%
1 Yr -37.9% -60.2% 11.7% 92.40%
3 Yr N/A* -10.0% 19.7% N/A
5 Yr N/A* -6.4% 16.9% N/A
10 Yr N/A* 6.4% 18.5% N/A

* Annualized

Return Ranking - Calendar

Period GERM Return Category Return Low Category Return High Rank in Category (%)
2021 14.6% -79.9% 24.2% 8.77%
2020 N/A -13.6% 178.2% N/A
2019 N/A 3.8% 63.8% N/A
2018 N/A -49.7% 21.5% N/A
2017 N/A -59.8% 54.4% N/A

Total Return Ranking - Trailing

Period GERM Return Category Return Low Category Return High Rank in Category (%)
YTD -32.7% -46.5% 25.3% 94.68%
1 Yr -37.9% -60.2% 28.3% 93.12%
3 Yr N/A* -13.2% 20.0% N/A
5 Yr N/A* -6.4% 16.9% N/A
10 Yr N/A* 6.4% 18.5% N/A

* Annualized

Total Return Ranking - Calendar

Period GERM Return Category Return Low Category Return High Rank in Category (%)
2021 14.6% -79.9% 24.2% 8.77%
2020 N/A -13.6% 178.2% N/A
2019 N/A 3.8% 63.8% N/A
2018 N/A -49.7% 22.2% N/A
2017 N/A -59.8% 54.4% N/A

GERM - Holdings

Concentration Analysis

GERM Category Low Category High GERM % Rank
Net Assets 28.2 M 732 K 46.2 B 79.26%
Number of Holdings 83 21 473 42.23%
Net Assets in Top 10 15.4 M 2.18 K 21.6 B 67.96%
Weighting of Top 10 53.20% 12.3% 80.8% 21.84%

Top 10 Holdings

  1. BioNTech SE ADR 7.54%
  2. Moderna Inc 6.74%
  3. QuidelOrtho Corp 6.39%
  4. Laboratory Corp of America Holdings 5.99%
  5. Bio-Rad Laboratories Inc Class A 5.80%
  6. Alnylam Pharmaceuticals Inc 5.00%
  7. Quest Diagnostics Inc 4.54%
  8. Atea Pharmaceuticals Inc Ordinary Shares 4.26%
  9. ETFMG Sit Ultra Short ETF 4.23%
  10. Quidel Corp 4.21%

Asset Allocation

Weighting Return Low Return High GERM % Rank
Stocks
95.28% 85.37% 106.13% 90.29%
Bonds
3.84% 0.00% 12.39% 1.46%
Cash
0.55% -0.10% 9.01% 52.91%
Convertible Bonds
0.33% 0.00% 0.37% 2.43%
Preferred Stocks
0.00% 0.00% 7.86% 93.20%
Other
0.00% -22.99% 3.38% 88.83%

Stock Sector Breakdown

Weighting Return Low Return High GERM % Rank
Healthcare
100.00% 59.26% 100.00% 45.63%
Utilities
0.00% 0.00% 0.00% 93.20%
Technology
0.00% 0.00% 22.69% 93.69%
Real Estate
0.00% 0.00% 7.13% 93.69%
Industrials
0.00% 0.00% 7.02% 93.69%
Financial Services
0.00% 0.00% 1.85% 95.15%
Energy
0.00% 0.00% 0.00% 93.20%
Communication Services
0.00% 0.00% 9.11% 93.20%
Consumer Defense
0.00% 0.00% 25.73% 94.17%
Consumer Cyclical
0.00% 0.00% 14.20% 94.17%
Basic Materials
0.00% 0.00% 14.83% 95.63%

Stock Geographic Breakdown

Weighting Return Low Return High GERM % Rank
US
73.29% 53.67% 104.41% 84.95%
Non US
21.99% 0.00% 45.40% 21.36%

Bond Sector Breakdown

Weighting Return Low Return High GERM % Rank
Corporate
83.51% 0.00% 83.51% 0.61%
Cash & Equivalents
11.72% 11.72% 100.00% 100.00%
Government
3.04% 0.00% 29.44% 1.23%
Municipal
1.73% 0.00% 1.73% 0.61%
Derivative
0.00% 0.00% 7.99% 94.48%
Securitized
0.00% 0.00% 0.00% 93.25%

Bond Geographic Breakdown

Weighting Return Low Return High GERM % Rank
US
3.55% 0.00% 11.75% 1.46%
Non US
0.29% 0.00% 3.33% 1.46%

GERM - Expenses

Operational Fees

GERM Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.68% 0.08% 3.13% 64.59%
Management Fee 0.68% 0.00% 1.25% 59.04%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

GERM Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

GERM Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

GERM Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover 39.00% 0.00% 238.00% 43.33%

GERM - Distributions

Dividend Yield Analysis

GERM Category Low Category High GERM % Rank
Dividend Yield 0.83% 0.00% 9.57% 16.11%

Dividend Distribution Analysis

GERM Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Monthly Annually

Net Income Ratio Analysis

GERM Category Low Category High GERM % Rank
Net Income Ratio 0.98% -2.54% 1.92% 6.36%

Capital Gain Distribution Analysis

GERM Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Semi-Annually Annually

Dividend Payout History

View More +

GERM - Fund Manager Analysis

Managers

Devin Ryder


Start Date

Tenure

Tenure Rank

Jun 17, 2020

1.95

2.0%

Devin Ryder began her career with ETF Managers Group LLC during the summer of 2017 and re‑joined ETF Managers Group LLC on a permanent basis in 2018 to be a part of the portfolio management team. Prior to joining ETF Managers Group LLC, Ms. Ryder was pursuing studies in the quantitative aspects of risk management and finance, for which she received a B.S. in Mathematics of Finance and Risk Management from the University of Michigan in 2017.

Frank Vallario


Start Date

Tenure

Tenure Rank

Jun 17, 2020

1.95

2.0%

Frank Vallario serves in the role of Chief Investment Officer for the ETF Managers Group, LLC. Mr. Vallario is responsible for the portfolio construction, trading, risk management and portfolio analysis processes associated with ETF strategies. Prior to his current role, Mr. Vallario has had a variety of senior roles over his 25-year career in financial services. He joined Oppenheimer Funds in 2017 where he was Head of Equity Portfolio Management for Smart Beta ETFs. Prior to that he was Senior Portfolio Manager at Columbia Threadneedle from September 2015 to June 2017 where he was responsible for the day to day management of the firm’s ETF business, which was acquired from his previous firm, Emerging Global Advisors (EGA). From September 2010 to September 2015, he was relationship manager at MSCI responsible for providing investment solutions to complex problems using MSCI Barra’s fundamental models and portfolio construction tools. Previously, he was a partner in a start-up asset management firm where he served as the director of portfolio management. Mr. Vallario began his career at UBS Global Asset Management where he spent over a decade in various quantitative portfolio management equity roles including equity market neutral, tactical asset allocation, structured active equities, enhanced index, passive management and factor research. Mr. Vallario serves on the Investment Committee for the Girl Scouts of Connecticut and is a University Affiliate at the University of Utah - David Eccles School of Business. He received a B.S. in Finance from Lehigh University and a M.B.A. with a concentration in Finance from Rutgers University.

Samuel Masucci


Start Date

Tenure

Tenure Rank

Jun 17, 2020

1.95

2.0%

Samuel Masucci, III has more than 25 years’ experience in investment banking, structured product development, sales and trading. In the last 5 years, he founded ETF Managers Group (ETFMG) hich has led to the launch of 15 funds and $3 billion in assets. . Prior to ETFMG, Mr. Samuel Masucci, III has held senior positions at Bear Stearns, UBS, SBC Warburg, and Merrill Lynch and has experience in creating, building and managing businesses for the issuance, sales and trading of: ETFs, index products, commodity products, hedge funds, ABS, and OTC structured products in the U.S. and Europe.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.54 2.12